1-4 of 4
Joanna Graczyk, MD
Close
Sort by
Journal Articles

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Abi Vijenthira, MD, Matthew C Cheung, MD, Chai Wye Phua, MD, Kelvin Chan, Joanna Graczyk, MD, Rena Buckstein, MD, Anca Prica, MD
Journal: Blood
Blood (2016) 128 (22): 1183.
https://doi.org/10.1182/blood.V128.22.1183.1183
Published: 2016
Journal Articles

Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients <65 Years of Age

Joanna Graczyk, MD FRCPC, Sunita Ghosh, PhD, Neil Chua, MD FRCPC, Douglas A. Stewart, MD FRCPC, Carolyn J. Owen, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 2520.
https://doi.org/10.1182/blood.V124.21.2520.2520
Published: 2014
Journal Articles

Granulocyte-Colony Stimulating Factor (G-CSF) in Secondary Prophylaxis for Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Cost-Effectiveness Analysis

Matthew C Cheung, Anca Prica, MD, Joanna Graczyk, MD, Rena Buckstein, MD, Kelvin KW Chan, MD
Journal: Blood
Blood (2014) 124 (21): 737.
https://doi.org/10.1182/blood.V124.21.737.737
Published: 2014
Journal Articles

G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision Analysis.

Joanna Graczyk, MD, Matthew Cheung, MD, Rena Buckstein, Kelvin Chan, MD
Journal: Blood
Blood (2010) 116 (21): 3831.
https://doi.org/10.1182/blood.V116.21.3831.3831
Published: 2010